Compare WYETH LTD with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs NATCO PHARMA - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD NATCO PHARMA WYETH LTD/
NATCO PHARMA
 
P/E (TTM) x 27.7 15.6 177.3% View Chart
P/BV x 5.3 3.1 174.2% View Chart
Dividend Yield % 1.3 1.5 87.8%  

Financials

 WYETH LTD   NATCO PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
NATCO PHARMA
Mar-18
WYETH LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0441,080 96.7%   
Low Rs818671 121.9%   
Sales per share (Unadj.) Rs298.6592.1 50.4%  
Earnings per share (Unadj.) Rs57.2188.4 30.4%  
Cash flow per share (Unadj.) Rs58.4206.3 28.3%  
Dividends per share (Unadj.) Rs17.008.25 206.1%  
Dividend yield (eoy) %1.80.9 193.8%  
Book value per share (Unadj.) Rs249.5833.6 29.9%  
Shares outstanding (eoy) m22.7236.90 61.6%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x3.11.5 210.9%   
Avg P/E ratio x16.34.6 350.0%  
P/CF ratio (eoy) x15.94.2 375.7%  
Price / Book Value ratio x3.71.1 355.3%  
Dividend payout %29.74.4 678.2%   
Avg Mkt Cap Rs m21,15732,311 65.5%   
No. of employees `0000.54.8 10.2%   
Total wages/salary Rs m4003,256 12.3%   
Avg. sales/employee Rs Th13,787.44,522.5 304.9%   
Avg. wages/employee Rs Th813.0674.0 120.6%   
Avg. net profit/employee Rs Th2,643.31,439.0 183.7%   
INCOME DATA
Net Sales Rs m6,78321,848 31.0%  
Other income Rs m353404 87.3%   
Total revenues Rs m7,13622,252 32.1%   
Gross profit Rs m1,6179,284 17.4%  
Depreciation Rs m27662 4.0%   
Interest Rs m6154 3.6%   
Profit before tax Rs m1,9388,872 21.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,920 32.9%   
Profit after tax Rs m1,3016,952 18.7%  
Gross profit margin %23.842.5 56.1%  
Effective tax rate %32.621.6 150.8%   
Net profit margin %19.231.8 60.3%  
BALANCE SHEET DATA
Current assets Rs m6,98421,307 32.8%   
Current liabilities Rs m2,0565,920 34.7%   
Net working cap to sales %72.670.4 103.2%  
Current ratio x3.43.6 94.4%  
Inventory Days Days9973 135.5%  
Debtors Days Days24107 22.5%  
Net fixed assets Rs m24414,986 1.6%   
Share capital Rs m227369 61.6%   
"Free" reserves Rs m5,44130,353 17.9%   
Net worth Rs m5,66830,760 18.4%   
Long term debt Rs m250-   
Total assets Rs m7,90137,151 21.3%  
Interest coverage x353.358.6 602.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 146.0%   
Return on assets %16.519.1 86.4%  
Return on equity %22.922.6 101.5%  
Return on capital %34.029.3 116.0%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1510,322 0.1%   
Fx outflow Rs m2,6772,978 89.9%   
Net fx Rs m-2,6627,343 -36.3%   
CASH FLOW
From Operations Rs m9234,636 19.9%  
From Investments Rs m317-11,155 -2.8%  
From Financial Activity Rs m-4816,509 -7.4%  
Net Cashflow Rs m759-18 -4,217.2%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.1 1.5 3,476.2%  
Indian inst/Mut Fund % 11.3 7.8 144.1%  
FIIs % 7.2 16.6 43.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 26.0 116.9%  
Shareholders   21,978 25,395 86.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   FRESENIUS KABI ONCO.  AJANTA PHARMA  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 115.2% YoY). Sales on the other hand came in at Rs 5 bn (up 27.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS